1Cademy - Association study between the use of RAS inhibitors with mortality among patients with hypertension hospitalized with COVID-19

Concept

Association study between the use of RAS inhibitors with mortality among patients with hypertension hospitalized with COVID-19

retrospective, multi-center study that included 1128 patients with hypertension diagnosed with COVID-19
of the 1128 patients, 188 were taking ACEI/ARBs
after adjustment for age, gender, comorbidities and in-hospital medications, the risk for mortality was found to be lower in the ACEI/ARB group vs those who weren't taking any ACEI/ARBs
subgroup propensity score-matched analyses revealed that ACEI/ARBs were more associated with lower mortality compared to other antihypertensive drugs
limitations of the study include the need to consider other confounding variables

0

1

Updated 2021-02-28

Contributors are:

Who are from:

References